Brillant Blue Versus Indocyanine Green for Macular Hole Surgery

Membranepeeling With Brillant Blue Versus Membranepeeling With Indocyanine Green for Patients With Idiopathic Macular Holes.

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00757471

Enrollment

Registered

2008-09-23

Start date

2008-08-31

Completion date

2015-08-31

Last updated

2016-01-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Idiopathic Macular Holes

Keywords

Macular hole surgery, membranepeeling, closure rate, vitreoretinal dyes

Brief summary

Macular Hole Surgery with two different Dyes

Interventions

PROCEDUREBrillant Blue

Membrane Peeling with Brillant Blue

PROCEDUREIndocyanine Green

Membrane Peeling with indocyanine Green

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

60 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Idiopathic stage 3 and 4 macular holes * Stage 2 macular holes, followed up for at least 6 months * Pseudophakic and phakic eyes * Age over 60 years

Exclusion criteria

* Traumatic macular holes * Secondary macular holes * Severe ocular diseases

Design outcomes

Primary

Measure	Time frame
Macular Hole Closure Rate	12 Months

Secondary

Measure	Time frame
Visual Acuity Microperimetry Optical Coherence Tomography	12 Months

Countries

Austria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026